Methods and compositions for treatment of epileptic disorders
Use of allosteric modulators and/or gaboxadol for the treatment of epileptic disorders in a subject in need thereof.
1. A method of treating seizures associated with CDKL5 deficiency disorder, comprising administering to a subject in need thereof a therapeutically effective amount of pharmaceutical composition comprising ganaxolone, wherein the therapeutically effective amount is administered three times per day.
2. The method of claim 1 , wherein ganaxolone is administered orally.
3. The method of claim 1 , wherein ganaxolone is administered as a tablet.
4. The method of claim 1 , wherein ganaxolone is administered as a capsule.
5. The method of claim 1 , wherein the pharmaceutical composition is a liquid composition and comprises about 50 mg/ml of ganaxolone.
6. The method of claim 1 , wherein the therapeutically effective amount is up to 1800 mg per day.
7. The method of claim 6 , wherein the therapeutically effective amount is administered as about 600 mg three times per day.
8. The method of claim 1 , wherein the therapeutically effective amount is up to 1350 mg per day.
9. The method of claim 8 , wherein the therapeutically effective amount is administered as about 450 mg three times per day.
10. The method of claim 1 , wherein the therapeutically effective amount is up to 900 mg per day.
11. The method of claim 10 , wherein the therapeutically effective amount is administered as about 300 mg three times per day.
12. The method of claim 1 , wherein the therapeutically effective amount is up to 450 mg per day.
13. The method of claim 12 , wherein the therapeutically effective amount is administered as about 150 mg three times per day.
14. The method of claim 1 , wherein the therapeutically effective amount is administered as up to about 21 mg/kg three times per day.
15. The method of claim 1 , wherein the therapeutically effective amount is administered as up to about 16 mg/kg three times per day.
16. The method of claim 1 , wherein the therapeutically effective amount is administered as up to about 6 mg/kg three times per day.
17. The method of claim 1 , wherein the frequency of seizures is reduced.
18. The method of claim 1 , wherein the frequency of seizures is reduced, the severity of seizures is reduced, or a combination thereof.